| Literature DB >> 32148813 |
Ali Madi Almajwal1, Iftikhar Alam1,2, Mahmoud Abulmeaty1, Suhail Razak1, Graham Pawelec3,4, Wajid Alam5.
Abstract
Dietary advanced glycation end products (dAGE) have profound negative effects on overall health, and their intake must be assessed. In this cross-sectional study, we investigated dAGE intake of 337 adult participants (180/157:M/F; age range 50-73 years). Data were collected on anthropometrics, body composition, dietary intake, selected blood biochemistry, immunological parameters, and antiradical capacity (50% hemolysis time; HT50). From the dietary data, dAGEs and phytochemical index (PI) were calculated. Mean BMI, % body fat (%BF), and fasting plasma glucose were all within the accepted normal range. Subjects with high dAGE intake had higher %BF, higher energy intake, and lower PI. They tended to have lower CD4/CD8 ratios and higher proportions of B cells and NK cells, but had significantly higher hs-CRP levels and lower HT50 values. Results on HT50 suggested that being >60 years of age enhanced dAGE-associated impairment of defense capacity in both those with low and high HT50 compared with those <60 years of age. Thus, overall dAGE consumption was high, but elderly participants had lower dAGE intake than younger adults. Indicators of nutritional status and immunological parameters of the subjects were found to be associated with dAGE intake, suggesting a potential impact on health.Entities:
Keywords: CRP; advanced glycationed end products; aging; dAGE; immunity; inflammation
Year: 2020 PMID: 32148813 PMCID: PMC7020308 DOI: 10.1002/fsn3.1389
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 2.863
General and clinical characteristics of study participants
|
Men total ( |
Men < 60 ( |
Men > 60 ( |
Women total ( |
Women < 60 ( |
Women > 60 ( |
| |
|---|---|---|---|---|---|---|---|
| Age (years) | 59.4 (3.55) | 53.3 (3.0)a | 65.5 (4.1)b | 58 (3.75) | 52.9 (3.8)c | 63.1 (3.7)d | .007 |
| Weight (kg) | 72.8 (16.5) | 76.5 (17.2)a | 68.9 (15.8)b | 67.3 (18.2) | 70.5 (18.4)c | 64.1 (17.9)d | .001 |
| BMI (kg/m2) | 22.65 (2.95) | 22.0 (3.1)a | 23.3 (2.8) | 21.2 (4.3) | 21.7 (4.1)c | 20.6 (4.5)c | .003 |
| %BF | 20.05 (5.25) | 19.0 (5.8)a | 21.1 (4.7)b | 22.1 (5.7) | 21.6 (4.1)c | 22.5 (7.2)c | .098 |
| Energy (kcal/day) | 2,173.5 (351) | 2,158 (336.8)a | 2,189 (365.1)a | 2,121.5 (417.3) | 2,176 (421.8)c | 2,067 (412.8)d | .2247 |
| Protein (g/day) | 59.4 (3.8) | 53.3 (3.0)a | 65.5 (4.6)b | 56.6 (4.25) | 51.8 (4.8)c | 61.4 (3.7)d | .0001 |
| Fats (g/day) | 71.25 (6.6) | 64.3 (12.3)a | 78.2 (13.8)b | 72.1 (6.55) | 65.1 (19.8)c | 79.1 (21.2)d | .253 |
| PI (%) | 19.75 (5.3) | 21.8 (5.1)a | 17.7 (5.5)b | 19.2 (6.05) | 21.9 (8.2)c | 16.5 (3.9)d | .460 |
| dAGE (kU/day) | 17,412 (6,276.1) | 21,703 (5,766.2)a | 13,121 (6,785.1)b | 19,618.5 (6,734.5) | 24,525 (7,346.9)c | 14,712 (6,122.8)d | .0027 |
| SBP (mm Hg) | 110.2 (18.25) | 103.6 (15.2)a | 116.8 (21.3)b | 115.05 (14.75) | 102.4 (16.3)c | 127.7 (13.2)d | .0110 |
| DBP (mm Hg) | 71.9 (20.55) | 65.2 (19.8)a | 78.5 (21.3)b | 77.6 (18.4) | 66.9 (18.9)c | 88.3 (17.9)d | .6001 |
| Cholesterol (mg/dl) | 151.7 (25.94) | 145.2 (25.6)a | 158.2 (26.3)b | 161.3 (27.45) | 151.6 (33.2)c | 171 (21.7)d | .005 |
| HDL‐C (mg/dl) | 47.7 (10.5) | 38.3 (9.8)a | 57.1 (11.2)b | 49.9 (10.6) | 41.1 (11.9)c | 58.7 (9.3)d | .0065 |
| LDL‐C (mg/dl) | 100.4 (21.2) | 102.5 (23.4)a | 98.3 (19.2)b | 108.8 (28.11) | 111.4 (31.2)c | 105.3 (28.71)d | .0032 |
| Triglycerides, TG (mg/dl) | 95.9 (23.3) | 87.6 (21.4)a | 104.2 (25.2)b | 105.8 (19.45) | 89.4 (17.1)c | 122.2 (21.8)d | .0001 |
| Glucose (mg/dl) | 87.25 (22.64) | 73.2 (23.4)a | 101.3 (21.9)b | 91.5 (23.05) | 78.3 (19.7)c | 104.7 (26.4)d | .099 |
| Hs‐CRP (mg/dl) | 2.15 (1.65) | 1.9 (1.6)a | 3.9 (17)b | 2.4 (1.6) | 1.7 (1.5)c | 3.1 (1.7)d | .4803 |
| CD4:CD8 | 1.25 (0.55) | 1.4 (0.5)a | 1.1 (0.6)b | 1.4 (0.75) | 1.5 (0.7)c | 1.3 (0.8)c | .038 |
| B cells (% of lymphocytes) | 3.6 (1.8) | 3.4 (1.9)a | 3.8 (1.7)a | 3.9 (1.9) | 3.7 (1.7)c | 4.1 (2.1)d | .406 |
| NK cells (% of lymphocytes) | 2.15 (1.6) | 1.9 (1.5)a | 2.4 (1.7)b | 1.95 (1.5) | 1.8 (1.3)c | 2.1 (1.7)d | .1496 |
| HT50 (minutes) | 128.695 (27.8) | 136.29 (26.41)a | 121.1 (29.11)b | 97.65 (27.76) | 101.5 (29.67)c | 93.8 (25.9)d | .001 |
Mean values followed by different letters as superscript (a, b) denote significant difference at p < .05 for men of two age categories.
Mean values followed by different letters as superscript (c, d) significant difference at p < .05 for women of two age categories.
Abbreviations: BF, Body fat; BMI, body mass index; dAGEs, dietary advanced glycation end products; DBP, diastolic blood pressure; HDL, high‐density lipids; Hs‐CRP, high sensitive C‐reactive protein; HT50, (50% hemolysis time); LDL, low density lipids; PI, phytochemical index; SBP, systolic blood pressure.
p‐value calculated is two‐tailed showing difference for mean values for men total versus women total. p significant at <.05.
General and clinical characteristics of the study population and dietary variables according to dAGE intake
|
Low dAGE intake (<15,000 kU/day) ( |
High dAGE intake (>15,000 kU/day) ( |
| |
|---|---|---|---|
| Age (year) | 59.2 (7.6) | 57.5 (7.4) | .059 |
| BMI (kg/m2) | 22.3 (2.19) | 22.9 (2.66) | .074 |
| BF (%) | 19.3 (2.68) | 23.0 (6.61) | .042 |
| Energy (kcal) | 2,013 (611) | 2,307 (521) | .025 |
| Protein (g) | 69.1 (34.5) | 71.2 (28.7) | .081 |
| Fats (g) | 67.9 (31.8) | 78.9 (43.1) | .037 |
| PI | 21.5 (4.24) | 16.2 (4.67) | .001 |
| dAGEs (kU/day) | 11,638 (6,745.3) | 25,389 (6,321.8) | <.0001 |
| High saturated fats diet (≥10.0 from energy) (%) | 32.7 | 67.3 | .002 |
| Low polyunsaturated fats diet (<6.0% from energy) (%) | 58.2 | 41.8 | .002 |
| High cholesterol diet (≥300.0 mg/day) (%) | 28.1 | 71.9 | .001 |
| High added‐sugar diet (≥10.0% of energy) (%) | 21.7 | 78.3 | .002 |
| High PI value (>20%) % | 87.7 | 12.3 | .001 |
| SBP (mm Hg) | 101 (16.8) | 123.1 (18.4) | .001 |
| DBP (mm Hg) | 68.5 (14.6) | 81.2 (27.3) | .001 |
| Cholesterol (mg/dl) | 151.3 (21.1) | 161.5 (17.5) | .001 |
| HDL‐C (mg/dl) | 41.2 (11.8) | 56.3 (12.1) | .001 |
| LDL‐C (mg/dl) | 106.2 (23.5) | 102.6 (27.2) | .121 |
| Triglycerides (mg/dl) | 91.4 (22.1) | 110.3 (21.8) | .001 |
| Glucose (mg/dl) | 72.5 (23.1) | 106.1 (26.8) | .001 |
| Hs‐CRP (mg/dl) | 2.4 (1.32) | 5.6 (1.55) | .001 |
| CD4:CD8 | 1.6 (0.49) | 1. 0 (0.61) | .081 |
| B cells (% of lymphocytes) | 3.4 (1.51) | 3.9 (1.91) | .071 |
| NK cells (% of lymphocytes) | 1.7 (0.96) | 2.7 (2.0) | .061 |
| HT50 (minutes) | 128.3 (27.45) | 108.9 (25.8) | .001 |
Abbreviations: BF, body fat; BMI, body mass index; dAGE, dietary advanced glycation end product; DBP, diastolic blood pressure; HDL, high‐density lipids; Hs‐CRP, high sensitive C‐reactive protein; HT50, (50% hemolysis time); PI, phytochemical index; SBP, systolic blood pressure.
p‐value calculated is two‐tailed. p significant at <.05.
Figure 1Percent dAGEs consumption distribution in meals in a day (a) and contribution of food groups in % dAGEs consumption (b). p‐value was calculated using two‐sample t test
Linear regression models testing the relationship of dietary AGE intake with hs‐CRP, CD4:CD8, B cells, and NK cells
| Hs‐CRP | CD4:CD8 | B cells | NK cells | |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
| Age (years) | 0.008 (0.002) | .020 | 0.078 (0.002) | .020 | 0.065 (0.092) | .010 | 0.072 (0.102) | .012 |
| Gender | 0.051 (0.879) | .641 | 0.101 (0.845) | .601 | 0.052 (0.879) | .641 | 0.081 (0.879) | .641 |
| BMI | 0.071 (0.012) | .001 | 0.101 (0.021) | .112 | 0.081 (0.012) | .101 | 0.073 (0.612) | .111 |
| BF | 0.062 (0.013) | .001 | 0.062 (0.045) | .001 | 0.030 (0.013) | .001 | 0.058 (0.042) | .041 |
| Energy intake | 0.061 (0.021) | .02 | 0.031 (0.054) | .051 | 0.051 (0.221) | .062 | 0.072 (0.121) | .052 |
| dAGE intake | 0.019 (0.008) | .041 | 0.115 (0.021) | .211 | 0.021 (0.008) | .211 | 0.082 (0.048) | .211 |
| PI | 0.018 (0.021) | .001 | 0.014 (0.030) | .001 | 0.081 (0.001) | .001 | 0.094 (0.011) | .011 |
Abbreviations: BF, body fat; BMI, body mass index; dAGE, dietary advanced glycation end product; PI, phytochemical index.
Figure 2Main and combined effects of dAGE, PI, and age on HT50 (a) and hs‐CRP (b) of the healthy subjects. Main dAGE, PI and age effects and their interaction effects were determined with the use of a multivariate ANOVA and post hoc Bonferroni correction